O&G SAQs · Intrapartum care — preterm birth
Preterm labour and birth — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on threatened preterm labour at 28+4 weeks in a regional hospital: first-30-minute priorities, full antenatal corticosteroid and magnesium sulfate prescriptions, tocolytic choice with contraindications, and the in-utero transfer decision. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks live in specifics: named drug, dose, route, interval, duration, threshold and contraindication. Write short labelled points, answer the sub-part asked, and never write "give steroids" when you could write the prescription.[1][2]
Reveal model answer and mark schemeShowHide
(a) Immediate priorities in the first 30 minutes (5 marks)
One mark per point with its justification, maximum five. [1][2]
- Confirm the diagnosis and the gestation. A cervical length of 14 mm with a fibronectin of 320 ng/mL in a symptomatic woman puts her in the highest-risk band; check the dating scan, not the chart heading.[9]
- Actively exclude the diagnoses that forbid delay — chorioamnionitis (fever, tachycardia, tenderness, offensive liquor), significant abruption (constant pain, tense tender uterus, bleeding) and non-reassuring fetal status. Here all three are absent, which is what permits tocolysis.[1][2]
- Give the first dose of antenatal corticosteroid now. Do not wait for the consultant, the scan or the retrieval service; the benefit is time-dependent and the commonest failure is a dose that was planned and never given.[1]
- Start magnesium sulfate for fetal neuroprotection because birth within 24 hours is plausible at 28+4 weeks.[4][5]
- Escalate the place of birth. Ring the tertiary unit and the retrieval service, and involve the neonatal team before the birth. Baseline bloods (FBC, CRP), MSU, high vaginal swab and group B streptococcus status are taken in the same 30 minutes.[8][2]
Reasoning marks are awarded for naming what each action is for — for example "tocolysis is only to buy the 48 hours for the steroid course and the transfer". [6]
(b) The two drugs that improve this baby's outcome (4 marks)
Two marks per prescription: one for the agent and dose, one for route, interval and duration. Marks are lost for "corticosteroids and magnesium" without numbers. [1][4]
| Drug | Dose | Route | Interval and duration |
|---|---|---|---|
| Betamethasone (Celestone Chronodose) | 11.4 mg | Intramuscular | Two doses, 24 hours apart — one course |
| Alternative: dexamethasone | 6 mg | Intramuscular | Four doses, 12 hours apart — one course |
| Magnesium sulfate — loading | 4 g | Intravenous over 20 to 30 minutes | Single loading dose |
| Magnesium sulfate — maintenance | 1 g per hour | Intravenous infusion | Until birth or 24 hours, whichever is first |
Add the monitoring in the same breath: hourly respiratory rate, deep tendon reflexes, conscious state and urine output while magnesium runs, and calcium gluconate 1 g intravenously over 10 minutes available as the antidote.[4][2]
(c) Tocolysis — agent, regimen, purpose, contraindications (4 marks)
One mark for the agent with a correct dose and regimen, one for stating the purpose, two for four absolute contraindications. [6][7]
- Agent: nifedipine immediate-release, commonly 20 mg orally, repeated once after 30 minutes if contractions continue (maximum 40 mg in the first hour), then 20 mg every 6 to 8 hours for up to 48 hours. Atosiban is the accepted alternative: 6.75 mg intravenous bolus over 1 minute, then 18 mg per hour for 3 hours, then 6 mg per hour for up to 45 hours.[6][7]
- Purpose: 48 hours, and only 48 hours — to complete the corticosteroid course, deliver magnesium sulfate, and achieve in-utero transfer. Tocolysis on its own does not improve neonatal outcome.[6]
- Four absolute contraindications (any four): chorioamnionitis; significant placental abruption; non-reassuring fetal status; advanced established labour; intrauterine fetal death; lethal fetal anomaly with a plan for birth; severe preeclampsia or eclampsia; any maternal condition requiring delivery.[1][2]
- Say why you did not choose a betamimetic: it is the class most likely to force treatment cessation for maternal adverse effects, with pulmonary oedema and tachyarrhythmia as the feared complications.[6]
(d) In-utero transfer (2 marks)
- Justify it in one sentence: at 28+4 weeks this baby needs a level of neonatal intensive care this hospital cannot provide, and the uterus is a better transport incubator than any retrieval cot — the Victorian extreme prematurity data show that a guideline promoting in-utero transfer changed both place of birth and survival at the earliest gestations.[8]
- Two circumstances to keep her and deliver locally: advanced labour where birth is likely before or during transfer; maternal instability (haemorrhage, sepsis, eclampsia) making transfer unsafe; a retrieval time longer than the anticipated time to birth. In any of these, deliver in place and call the neonatal retrieval team to come to you.[8][2]
References9ShowHide
- [1]Stock SJ, Thomson AJ, Papworth S, et al. Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74 BJOG, 2022.PMID 35172391
- [2]American College of Obstetricians and Gynecologists Practice Bulletin No. 171: Management of Preterm Labor Obstet Gynecol, 2016.PMID 27661654
- [3]Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial Lancet, 2006.PMID 16765760
- [4]Shepherd ES, Goldsmith S, Doyle LW, Middleton P, Marret S, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus Cochrane Database Syst Rev, 2024.PMID 38726883
- [5]Crowther CA, Hiller JE, Doyle LW, Haslam RR Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial JAMA, 2003.PMID 14645308
- [6]Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, et al. Tocolytics for delaying preterm birth: a network meta-analysis (0924) Cochrane Database Syst Rev, 2022.PMID 35947046
- [7]van Vliet EOG, Nijman TAJ, Schuit E, Heida KY, Opmeer BC, et al. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial Lancet, 2016.PMID 26944026
- [8]Gordon HG, Shub A, Stewart MJ, Kane SC, Cheong JL, et al. In-utero transfer, survival-focused care and survival to 28-days at 22-24 weeks' gestation pre- and post- implementation of an extreme prematurity management guideline in Victoria, Australia BMJ Paediatr Open, 2024.PMID 39433430
- [9]Stock SJ, Horne M, Bruijn M, White H, Heggie R, et al. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study Health Technol Assess, 2021.PMID 34498576